In addition, pharmacological stimulation of SIRT1 attenuates hepatic steatosis through PRKA-independent, SIRT1-mediated autophagy and attenuates hepatic ischemia-reperfusion injury by restoring mitochondrial function and enhanced autophagy [29,124]. The gene discussed is SIRT1; the disease is fatty liver disease.